Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

ERR4976615

· D

e27d3871-3fe5-53b5-a609-e418a9fb4694

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
D
subtype
D
overall_survival_months
24

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.350
  • SPERMATOGENESIS+0.340
  • PANCREAS_BETA_CELLS+0.090
  • BILE_ACID_METABOLISM+0.070
  • HEDGEHOG_SIGNALING-0.020
  • MYOGENESIS-0.020
  • COAGULATION-0.080
  • NOTCH_SIGNALING-0.080
  • WNT_BETA_CATENIN_SIGNALING-0.080
  • PEROXISOME-0.110

Top 10 suppressed

  • TGF_BETA_SIGNALING-0.470
  • TNFA_SIGNALING_VIA_NFKB-0.440
  • UNFOLDED_PROTEIN_RESPONSE-0.440
  • MYC_TARGETS_V1-0.430
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.430
  • IL6_JAK_STAT3_SIGNALING-0.400
  • OXIDATIVE_PHOSPHORYLATION-0.380
  • PROTEIN_SECRETION-0.370
  • MTORC1_SIGNALING-0.360
  • ADIPOGENESIS-0.350

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

6 twins match this tumor's tissue · 4 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1BS_4GTESTSE
brain-umap@2
Ganglioglioma0.955
2SRR934787
brain-umap@2
0.953
3ERR4976613
breast-umap@18
D0.953
4SRR26320081
bladder-landscape@3
0.951
5SRR1797231
lung-landscapes@6
cohortSC0.949
6MDT-AP-3189
medullo-epn-umap@date-based
MedMedulloblastoma0.946
7SRR602927
brain-umap@2
GTEX0.945
8SRR4195666
colon-landscapes@1
0.945
9SRR1478032
brain-umap@2
GTEX0.944
10ERR4976608
breast-umap@18
D0.944

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.350Remibrutinib— uncovered
SPERMATOGENESIS0.340Inavolisib— uncovered
PANCREAS_BETA_CELLS0.090Cobimetinib— uncovered
BILE_ACID_METABOLISM0.070Inavolisib— uncovered